<DOC>
	<DOCNO>NCT02663128</DOCNO>
	<brief_summary>The purpose study measure much new tablet formulation AZD3293 get blood stream long take body get rid , compare current tablet formulation AZD3293 . The effect high fat meal quickly body absorbs new tablet formulation also evaluate . In addition side effect study drug use new current tablet formulation evaluate . The study last 22 day , screen require within 30 day prior start study .</brief_summary>
	<brief_title>A Study AZD3293 ( LY3314814 ) Healthy Participants</brief_title>
	<detailed_description />
	<criteria>Male participant : Will sterile ( include vasectomy ) agree use effective method birth control donate sperm study 3 month follow last dose investigational product Female participant : Women childbearing potential due surgical sterilization confirm medical history menopause Are able eat highfat , highcalorie meal within defined time limit abide food restriction throughout study Have history current , significant ophthalmic disease , determine investigator ophthalmologist Have vitiligo clinically significant disorder skin pigmentation determine investigator dermatologist History presence gastrointestinal , hepatic renal disease condition know interfere absorption , distribution , metabolism excretion drug History previous ongoing psychiatric disease/condition Have abnormality 12lead electrocardiogram ( ECG ) , opinion investigator , increase risk associate participate study , history significant dysrhythmias atrioventricular ( AV ) block ( include first degree AV block ) . Participants history persistent PR interval great ( &gt; ) 200 millisecond ( msec ) exclude Have prolong Fridericiacorrected QT interval ( QTcF ) &gt; 470 msec Have clinically significant abnormal blood pressure heart rate ( supine ) determine investigator Have history current cardiovascular , respiratory , hepatic , renal , gastrointestinal , endocrine , hematological , neurological disorder capable significantly alter absorption , metabolism , elimination drug Are unwilling comply dietary requirements/restrictions study Evidence active renal disease ( e.g , diabetic renal disease , polycystic kidney disease ) calculate creatinine clearance &lt; 50 milliliter per minute ( mL/min )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>